Activism Snapshot
Macy’s and Arkhouse entered a cooperation agreement and settled, for now their “hostile” acquisition situation. However, while no longer “hostile” (maybe), Arkhouse and Brigade still are pushing for Macy’s to sell and their new directors will sit on the board committee assessing the offer and alternatives. It seems the balance has tilted in favor of Arkhouse/Brigade, but nothing is settled yet. Note that next week we’ll take another look at how 2024’s cooperation agreements have been received by shareholders after their announcement. For those announced at the start of April — MRC, ELAN, and TWLO — each is down since so far, but it will take time for the activists and new directors to make a real impact, so nobody should read too much into the change in price yet.
Catch up on the latest Activism and Governance research from Boardroom Alpha:
- Vanguard & Blackrock Should Vote “AGAINST” Directors at These April Shareholder Meetings
- Weekly Activism & Executive Moves Review (April 5)
- AGM Update April 3, 2024: Disney (DIS) Proxy Contest, Plus Carnival Corp (CCL), FuelCell Energy (FCEL)
- Weekly Activism & Executive Moves Review (Mar 29)
CEO / CFO Moves Snapshot
Angi Inc. (ANGI) CEO Joesph Levin steps down and hands the CEO role over to long-time Angi insider Jeffrey Kip. Kip has served as President of Angi since November 2023 and CEO of Angi International since April 2016. Levin will remain CEO of Angi’s parent IAC (IAC). Changes at Illumina (ILMN) continue as CFO Joydeep Goswami steps down after a little over 1.5 years and seeing the stock drop almost -22% over his tenure. New CEO Ankur Dhingra takes over after having served as CFO at Summit Therapeutics In. (SMMT) and CAREDx (CDNA) before that. Despite Icahn winning his fight at Illumina in 2023, the company’s path has not yet changed course and investors will be hoping for a change in trajectory soon. ILMN shareholders will get their chance to vote their opinions on May 16th at the annual shareholder meeting.
ACTIVISM UPDATE
LATEST COOPERATION AGREEMENTS
TARGET | 1-Year TSR | ACTIVIST | SUMMARY | FILING | DATE | STOCK CHANGE | DAYS SINCE |
---|---|---|---|---|---|---|---|
MRC GLOBAL INC (MRC) | 33.7% | Engine Capital |
|
View Filing | 2024-04-02 | -0.4% | 10 |
ELANCO ANIMAL HEALTH INC (ELAN) | 61.2% | Ancora |
|
View Filing | 2024-04-01 | -7.6% | 11 |
TWILIO INC (TWLO) | 2.8% | Sachem Head |
|
View Filing | 2024-04-01 | -1.8% | 11 |
NOTABLE 13D ACTIVIST FILINGS
Quick Link: See last week’s 13D filings update
FILED | TICKER | COMPANY | FILED BY | OWNERSHIP | 1-Year TSR | SUMMARY | FILING |
---|---|---|---|---|---|---|---|
2024-04-12 | CULP | CULP INC | 22NW Fund, LP | 9.90 | -15.6% | summary | 2024-04-12 – SC 13D |
2024-04-12 | TEF | TELEFONICA S A | CRITERIA CAIXA, S.A.U. | 5.00 | 2.2% | summary | 2024-04-12 – SC 13D |
2024-04-08 | DCO | DUCOMMUN INC | Albion River Management LLC | 9.00 | 3.7% | summary | 2024-04-08 – SC 13D |
2024 PROXY CONTEST RESULTS
TICKER | COMPANY | ACTIVIST | MEETING DATE | SUMMARY |
---|---|---|---|---|
M | MACY’S INC | Arkhouse Management | May 17, 2024 | RESULT SUMMARY
FIGHT SUMMARY
|
DIS | WALT DISNEY CO | Trian / Nelson Peltz Blackwell’s |
April 3, 2024 | RESULT SUMMARY: DISNEY / IGER PREVAIL
Proxy Contest Summary Notes
|
ELAN | ELANCO ANIMAL HEALTH INC | Ancora | N/A | RESULT
Proxy Fight Summary
|
MRC | MRC GLOBAL INC | ENGINE CAPITAL | N/A | RESULT
Proxy Fight Summary
|
SBUX | STARBUCKS CORP | Strategic Organizing Center (SOC) | March 15, 2024 | Vote Results – MARCH 15, 2024
Proxy Fight Summary
|
WH | WYNDHAM HOTELS & RESORTS INC | CHOICE HOTELS INTERNATIONAL INC | N/A | RESULT
March 11, 2024 — Choice abandons it’s takeover effort and proxy contest BACKGROUND
|
LATEST PROXY CONTEST FILINGS
TICKER | COMPANY | LATEST PROXY | SUMMARY | FILED BY | FILINGS |
---|---|---|---|---|---|
AHT | ASHFORD HOSPITALITY TRUST INC | 2024-04-09 – PREC14A |
|
Blackwells Capital LLC | 2024-04-09 – PREC14A |
BHR | BRAEMAR HOTELS & RESORTS INC | 2024-04-11 – PREC14A |
|
BRAEMAR HOTELS & RESORTS INC | 2024-04-11 – DEFA14A 2024-04-11 – DEFA14A 2024-04-11 – PREC14A 2024-04-02 – PREC14A |
Blackwells Capital LLC | 2024-04-12 – DFAN14A 2024-04-10 – DFAN14A 2024-04-10 – DFAN14A 2024-04-03 – DEFC14A |
||||
HCC | WARRIOR MET COAL INC | 2024-03-14 – DEFC14A |
|
WARRIOR MET COAL INC | 2024-04-11 – DEFA14A 2024-04-11 – DEFA14A |
American Federation of Labor Congress of Industrial Organizations | 2024-03-26 – DFAN14A | ||||
NSC | NORFOLK SOUTHERN CORP | 2024-03-26 – DEFC14A |
Activist / Ancora Summary
|
NORFOLK SOUTHERN CORP | 2024-04-12 – DEFA14A 2024-04-12 – DEFA14A 2024-04-11 – DEFA14A 2024-04-11 – DEFA14A 2024-04-11 – DEFA14A 2024-04-11 – DEFA14A 2024-04-11 – DEFA14A 2024-04-11 – DEFA14A 2024-04-11 – DEFA14A |
Ancora | 2024-04-08 – DFAN14A 2024-04-05 – DFAN14A 2024-03-28 – DFAN14A 2024-03-26 – DEFC14A 2024-03-26 – DFAN14A |
||||
CCI | CROWN CASTLE INC | 2024-04-11 – DEFC14A |
|
CROWN CASTLE INC | 2024-04-11 – DEFA14A 2024-04-11 – DEFA14A 2024-04-11 – DEFA14A 2024-04-11 – DEFA14A 2024-04-11 – DEFC14A 2024-04-11 – DEFA14A 2024-04-10 – DEFA14A |
Boots Parallel 1, LP | 2024-04-11 – DFAN14A 2024-04-10 – PRRN14A |
||||
GNK | GENCO SHIPPING & TRADING LTD | 2024-04-03 – PREC14A |
|
GENCO SHIPPING & TRADING LTD | 2024-04-08 – PREC14A 2024-04-03 – DEFA14A 2024-04-03 – PREC14A |
EAF | GRAFTECH INTERNATIONAL LTD | 2024-04-02 – DEFC14A |
|
GRAFTECH INTERNATIONAL LTD | 2024-04-12 – DFAN14A 2024-04-02 – DEFC14A 2024-04-02 – DEFA14A |
Undavia Nilesh | 2024-04-03 – DFAN14A 2024-03-26 – PRRN14A |
||||
MASI | MASIMO CORP | 2023-05-24 – DEFC14A |
|
MASIMO CORP | 2024-04-02 – DEFA14A 2024-04-01 – DEFA14A |
Politan Capital Management LP | 2024-03-25 – DFAN14A | ||||
MFIN | MEDALLION FINANCIAL CORP | 2024-04-10 – PREC14A |
|
ZimCal Asset Management, LLC | 2024-04-12 – DFAN14A 2024-04-11 – DFAN14A 2024-04-10 – PREC14A |
SBOW | SILVERBOW RESOURCES INC | 2024-03-29 – PREC14A |
|
SILVERBOW RESOURCES INC | 2024-04-10 – DEFA14A 2024-04-09 – DEFC14A 2024-04-09 – DEFA14A 2024-03-28 – DEFA14A 2024-03-28 – PREC14A 2024-03-28 – DEFA14A 2024-03-28 – DEFA14A |
Kimmeridge Energy Management Company, LLC | 2024-04-11 – DFAN14A 2024-04-11 – DFAN14A 2024-04-10 – DEFC14A 2024-04-09 – PRRN14A 2024-04-01 – DFAN14A |
||||
SCOR | COMSCORE INC |
|
180 DEGREE CAPITAL CORP | 2024-03-04 – DFAN14A | |
COMSCORE INC | 2024-03-25 – DEFA14A | ||||
WSR | WHITESTONE REIT | 2024-04-04 – DEFC14A |
|
Erez REIT Opportunities LP | 2024-04-05 – DEFA14A 2024-04-04 – DEFC14A 2024-04-02 – PRRN14A 2024-03-19 – PREC14A |
WHITESTONE REIT | 2024-04-09 – DFAN14A 2024-04-05 – DEFC14A 2024-04-02 – PRRN14A |
||||
XPER | XPERI INC | 2024-03-25 – PREC14A |
|
Rubric Capital Management LP | 2024-04-02 – PRRN14A 2024-03-26 – PRRN14A2024-03-11 – DFAN14A 2024-03-08 – PREC14A |
XPERI INC | 2024-03-25 – PREC14A |
CEO & CFO MOVES
CEO Moves: ANGI, HLIT, HXL, NEON, NRIM, TDOC, VMEO, ZURA
CFO Moves: ARQT, CMBM, FIGS, GANX, GLT, HNRG, ILMN, IPI, ISSC, LIQT, MEI, PEV, PRLD, SLNH, SNSE, THR, XXII, ZCAR
COMPANY | MARKET CAP / TSR | ROLE | LEAVING | JOINING | JOINER BIOGRAPHY |
---|---|---|---|---|---|
22ND CENTURY GROUP INC (XXII) | Mkt Cap: $5.6M 1-Yr TSR: -99.0% |
CFO | R. Hugh Kinsman 1.8 yrs ; -93.8% TSR |
Daniel Otto | Mr. Otto, age 34, has served as the Company’s Corporate Controller since July 2022 where he was responsible for accounting, SEC external reporting, treasury, tax and other finance management functions. Prior to joining the Company, Mr. Otto served as a Senior Manager at Deloitte & Touche LLP providing audit and accounting advisory services to public companies, ranging from small to large…read full bio |
ANGI INC (ANGI) | Mkt Cap: $1.1B 1-Yr TSR: -1.4% |
CEO | Joseph Levin 1.5 yrs ; -17.4% TSR |
Jeffrey W Kip | Mr. Kip, age 56, has served as President of Angi since November 2023 and as Chief Executive Officer of Angi International (formerly known as HomeAdvisor International) since April 2016. Prior to serving in this role, Mr. Kip served as Chief Financial Officer of IAC Inc. (home to dozens of popular online brands and services used by millions of consumers each day and Angi’s…read full bio |
ARCUTIS BIOTHERAPEUTICS INC (ARQT) | Mkt Cap: $1.2B 1-Yr TSR: -4.0% |
CFO | John W Smither .7 yrs *interim; ; 6.3% TSR |
David Topper | Mr. Topper, age 66, joins the Company from Inmagene Biopharmaceuticals Co. Ltd. (“Inmagene”), a global clinical stage pharmaceutical company, where he has served as Chief Financial Officer since August 2023. Prior to Inmagene, Mr. Topper held significant positions in various organizations, including serving as a partner for capital markets at General Atlantic, a global growth equity fi…read full bio |
CAMBIUM NETWORKS CORP (CMBM) | Mkt Cap: $116.5M 1-Yr TSR: -75.5% |
CFO | John Monroy Becerril .2 yrs |
Jacob Sayer | Prior to joining Cambium Networks, Mr. Sayer has had various roles at Sensata Technologies Holding plc, including Vice President, Finance – Investor Relations from April 2020 to March 2024; Vice President, CFO, Industrial, Aerospace and Heavy Vehicle Business Units from January 2019 to April 2020; Vice President, CFO, Automotive Sensors Business Unit from January 2016 to January 2019; Treasu…read full bio |
FIGS INC (FIGS) | Mkt Cap: $871.6M 1-Yr TSR: -23.0% |
CFO | Daniella Turenshine 2.3 yrs ; -55.6% TSR |
Kevin Fosty (interim) |
Mr. Fosty, age 52, has served as the Company’s VP, Controller since April 2021. In this role, he has been responsible for the Company’s accounting, financial reporting, tax and financial controls. Prior to joining the Company, from July 2011 to April 2021, Mr. Fosty served as senior director at The Siegfried Group, LLP, within the finance and corporate accounting group, providing contr…read full bio |
GAIN THERAPEUTICS INC (GANX) | Mkt Cap: $54.5M 1-Yr TSR: -28.8% |
CFO | Gianluca Fuggetta .1 yrs |
Gene Mack | Gene has over 25 years of experience in the life sciences sector spanning clinical research, financing and capital markets, investing, corporate strategy and business development. Prior to joining Gain, Gene was CFO at privately held Imcyse SA between 2021 and 2023. Prior to Imcyse, Gene was CFO at OncoC4, a privately held biotechnology company that spun out of Merck & Co’s (MSD) $4…read full bio |
HALLADOR ENERGY CO (HNRG) | Mkt Cap: $166.4M 1-Yr TSR: -49.6% |
CFO | Lawrence D Martin 8.0 yrs ; 2.6% TSR |
Marjorie Anne Hargrave | Ms. Hargrave, 60, is an accomplished financial executive with experience across a variety of industries, including the power sector. Since 2023, Ms. Hargrave served as Chief Financial Officer of Leanin’ Tree, Inc., a manufacturer and distributor of greeting cards. Between 2019 and 2022, she served as the President and CFO of Enservco Corporation, a diversified national provider o…read full bio |
HARMONIC INC (HLIT) | Mkt Cap: $1.2B 1-Yr TSR: -29.6% |
CEO | Patrick Harshman 18.1 yrs ; 4.0% TSR |
Nimrod Ben-Natan | Mr. Ben-Natan joined the Company in 1996, was named Vice President of Product Marketing, Solutions and Strategy in 2007, and was appointed Senior Vice President and General Manager, Cable Products, in June 2012. From 1993 to 1996, Mr. Ben-Natan served as an Embedded Software Engineer at Orckit Communications Ltd., a digital subscriber line developer. Previously, he worked on wireless communication…read full bio |
HEXCEL CORP (HXL) | Mkt Cap: $5.4B 1-Yr TSR: -4.0% |
CEO | Nick L Stanage 10.7 yrs ; 7.4% TSR |
Thomas C. Gentile III | Mr. Gentile, 59, was the President and Chief Executive Officer of Spirit AeroSystems Holdings, Inc. from August 2016 through September 2023. Previously, he held a succession of leadership roles at General Electric (“GE”) across the U.S., France and Australia from 2008 through 2016, including President & Chief Operating Officer of GE Capital Corporation, President & CEO of GE He…read full bio |
ILLUMINA INC (ILMN) | Mkt Cap: $20.8B 1-Yr TSR: -43.1% |
CFO | Joydeep Goswami 1.8 yrs *interim; ; -21.6% TSR |
Ankur Dhingra | Ankur Dhingra is joining Illumina as Chief Financial Officer (CFO), leading Illumina’s financial planning and analysis, accounting, investor relations, internal audit, tax, and treasury functions. Dhingra brings a breadth of experience from the life sciences tools, diagnostics, and pharmaceutical industries. He formerly was CFO at Summit Therapeutics Inc. (NASDAQ: SMMT), and prior to that wa…read full bio |
INNOVATIVE SOLUTIONS & SUPPORT INC (ISSC) | Mkt Cap: $115.4M 1-Yr TSR: -12.6% |
CFO | Relland Winand .4 yrs ; .3% TSR |
Jeffrey Digiovanni | Jeffrey DiGiovanni, age 47, served as Senior Vice President and Chief Financial Officer of StoneMor Inc. (formerly NYSE: STON), a provider of funeral and cemetery products and services in the death care industry, from September 2019 to May 2023, and prior to that, served as StoneMor Inc.’s Chief Accounting Officer from September 2018 to September 2019. From January 2…read full bio |
LIQTECH INTERNATIONAL INC (LIQT) | Mkt Cap: $15.3M 1-Yr TSR: -23.4% |
CFO | Simon Seidelin Stadil 2.4 yrs ; -66.2% TSR |
TBD | TBD |
METHODE ELECTRONICS INC (MEI) | Mkt Cap: $444.9M 1-Yr TSR: -69.2% |
CFO | Ronald Lg Tsoumas 6.3 yrs ; -16.4% TSR |
David A Rawden (interim) |
David Rawden, age 66, has been a Director at AlixPartners LLP since 2008. Mr. Rawden’s assignments through AlixPartners have included being Interim Chief Financial Officer for Simtry, a privately held pharmaceutical CDMO company, from August 2023 to February 2024, Interim Chief Financial Officer at Academic Partnerships, a privately held educational online program manager company, from July …read full bio |
NEONODE INC (NEON) | Mkt Cap: $22.7M 1-Yr TSR: -79.3% |
CEO | Urban Forssell 4.3 yrs ; -4.1% TSR |
Fredrik Nihlen (interim) |
Fredrik Nihlen , age 38, commenced employment as Chief Financial Officer, Treasurer and Secretary of our company on August 2, 2021. Mr. Nihlen previously served as Finance Director IFS Nordics at IFS Sverige AB (“IFS”) since November 2019. Prior to joining IFS, Mr. Nihlen held the position of Group Chief Financial Officer at Cinnober Financial Technology AB from September 2018 to October 2019. Bef…read full bio |
NORTHRIM BANCORP INC (NRIM) | Mkt Cap: $252.8M 1-Yr TSR: 7.0% |
CEO | Joseph M Schierhorn 6.8 yrs ; 11.1% TSR |
Michael G Huston | Mr. Huston is currently the President of the Bank and was appointed President and Chief Lending Officer of the Bank in March 2022. He relinquished the title of Chief Lending Officer in March 2023. Mr. Huston was originally hired as the Executive Vice President and Chief Lending Officer of the Bank in 2017. He joined the Bank with over 25 years of experience that includes serving as the Execut…read full bio |
PHOENIX MOTOR INC (PEV) | Mkt Cap: $17.0M 1-Yr TSR: 24.8% |
CFO | James Mark Hastings .1 yrs |
TBD | TBD |
PRELUDE THERAPEUTICS INC (PRLD) | Mkt Cap: $286.7M 1-Yr TSR: -25.3% |
CFO | Laurent Chardonnet 2.4 yrs ; -44.0% TSR |
Bryant David Lim (interim) |
Mr. Lim, age 53, has served as the Company’s Chief Legal Officer and Corporate Secretary since February 2023 and will continue in those roles in addition to his new role. Prior to joining the Company, Mr. Lim served as Senior Vice President, General Counsel and Chief Business Officer at Aceragen Inc., a biotechnology company previously known as Idera Pharmaceuticals, from September 2018 to F…read full bio |
SENSEI BIOTHERAPEUTICS INC (SNSE) | Mkt Cap: $27.3M 1-Yr TSR: -28.8% |
CFO | Erin Colgan 2.3 yrs ; -52.3% TSR |
TBD | TBD |
SOLUNA HOLDINGS INC (SLNH) | Mkt Cap: $6.3M 1-Yr TSR: -65.7% |
CFO | David C Michaels 1.0 yrs *interim; ; -58.0% TSR |
John Tunison | Tunison has held multiple leadership roles in energy and financing, including with Trussway, Velocys plc, Ascend Performance Materials, Univar, and Shell Oil Company. A former nuclear engineer and submarine officer with the US Navy, he also holds an M.B.A. in Finance from the University of Rhode Island and a bachelor’s degree in Political Science from the U.S. Naval Academy….read full bio |
TELADOC HEALTH INC (TDOC) | Mkt Cap: $2.4B 1-Yr TSR: -43.2% |
CEO | Jason N Gorevic 14.8 yrs ; -7.6% TSR |
Mala Murthy | Ms. Murthy, 60, has served as the Company’s Chief Financial Officer since 2019, in which capacity she has led the Company’s global finance organization, including accounting, financial planning & analysis and investor relations. Previously, from 2016 to 2019, she served as Chief Financial Officer of Global Commercial Services at American Express, a financial services company, where…read full bio |
THERMON GROUP HOLDINGS INC (THR) | Mkt Cap: $1.1B 1-Yr TSR: 36.5% |
CFO | Kevin Fox 3.2 yrs ; 22.1% TSR |
Greg Lucas | Mr. Lucas, age 48, has served as the Company’s Corporate Controller since 2021, in which capacity he manages the Company’s accounting and financial reporting organization. Prior to joining the Company, Mr. Lucas was the Assistant Corporate Controller for BNSF Railway Company from 2019 to 2020, a leading freight transportation company. From 2017 to 2019, Mr. Lucas was the Controller of …read full bio |
VIMEO INC (VMEO) | Mkt Cap: $621.8M 1-Yr TSR: 2.5% |
CEO | Adam Gross .6 yrs *interim; ; 10.3% TSR |
Philip D Moyer | Philip Moyer , age 58, was appointed to serve as our Chief Executive Officer and a member of our Board effective April 8, 2024. Prior to joining Vimeo, Mr. Moyer served as Global VP of Applied AI Engineering and Business Development and VP of Strategic Industries, Google Cloud, a division of Alphabet Inc., a role he held since July 2019. Prior to Alphabet, Mr. Moyer was Director of Financial Servi…read full bio |
ZOOMCAR HOLDINGS INC (ZCAR) | Mkt Cap: $16.7M 1-Yr TSR: -96.0% |
CFO | Geiv Dubash 1.1 yrs ; -89.9% TSR |
Sachin Gupta (interim) |
Sachin Gupta has served as the Company’s Financial Controller since May 2019 and is responsible for all aspect of Accounting, Finance, Treasury, Taxation, Statutory Audits, and Internal Audits of all the entities of Zoomcar globally. Mr. Gupta has more than 12 years of accounting and business experience. Prior to Zoomcar, Mr. Gupta spent two years as a Financial Planning and Analysts (&ldquo…read full bio |
ZURA BIO LTD (ZURA) | Mkt Cap: $125.1M 1-Yr TSR: -76.1% |
CEO | Someit Sidhu 2.8 yrs ; -36.8% TSR |
Robert Lisicki | Robert Lisicki has served as President and Chief Operating Officer since January 2024. He will become our Chief Executive Officer and a director on April 8, 2024. He is an experienced executive leader with a career spanning 30 years in the biopharmaceutical industry. Mr. Robert Lisicki has been serving on the boards of Adiso Therapeutics and Cadrenal Therapeutics, Inc. since October 2023 and July …read full bio |